Previous close | 6.51 |
Open | 6.49 |
Bid | 6.57 x 500 |
Ask | 6.60 x 500 |
Day's range | 6.48 - 6.73 |
52-week range | 1.78 - 6.90 |
Volume | |
Avg. volume | 1,665,093 |
Market cap | 2.033B |
Beta (5Y monthly) | 1.35 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.73 |
Earnings date | 29 Feb 2024 - 04 Mar 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 8.00 |
Amneal Pharmaceuticals ( NASDAQ:AMRX ) First Quarter 2024 Results Key Financial Results Revenue: US$659.2m (up 18% from...
Amneal Pharmaceuticals reports significant revenue and EBITDA growth in Q1 2024, driven by new product launches and strong market performance.
BRIDGEWATER, N.J., May 03, 2024--AMNEAL REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS